Teleflex (TFX) Tops Q4 EPS by 12c, provides guidance

Teleflex (NYSE: TFX) reported Q4 EPS of $3.38, $0.12 better than the analyst estimate of $3.26. Revenue for the quarter came in at $773.9 million versus the consensus estimate of $768.72 million.

GUIDANCE:

2024 guidance summary:

GAAP revenue growth guidance range of 3.60% to 4.60%

Constant currency revenue growth guidance range of 3.75% to 4.75%

GAAP EPS from continuing operations guidance range of $5.69 to $6.09

Teleflex sees FY2024 EPS of $13.55-$13.95, versus the consensus of $13.84.

For earnings history and earnings-related data on Teleflex (TFX) click here.

You May Also Be Interested In

• Johnson & Johnson (JNJ) Tops Q2 EPS by 4c; raises guidance
• Johnson & Johnson beats estimates but shares dip
• Elevance Health Inc. (ELV) Tops Q2 EPS by 124c, raises guidance